http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5407849

Outgoing Links

Predicate Object
contentType Letter|Comment
endingPage 5721
issn 2473-9537
issueIdentifier 22
pageRange 5716-5721
publicationName Blood advances
startingPage 5716
bibliographicCitation Wudhikarn K, Loghavi S, Mangaonkar AA, Al-Kali A, Binder M, Carr R, Reichard K, Finke C, Howard M, Gangat N, Tefferi A, Komrokji R, Ali N, Lasho T, Ketterling R, Padron E, Patnaik MM. SF3B1-mutant CMML defines a predominantly dysplastic CMML subtype with a superior acute leukemia-free survival. Blood Adv. 2020 Nov 24;4(22):5716–21. PMID: 33216886; PMCID: PMC7686903.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f75518af161e16a3678c2805ff4919b9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b52a84edec3b55a92b59e0c7f80fbb3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dda9d6ee79bdd09c0b06a6ab938ffa39
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ee352a90b054d2cd76ea538f0b82d14
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1c9de83efd1bd8006cb13f5a5f4a912
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d44eccb2429da054c268d5ab1142c70f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20b265c6b44dc5ee6d95f8ce9be6c408
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e8c2159bb992bc916bb373644f61ac2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad9dba381b165c82fc08be326d151413
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61d0bc6c2a0c8c21c57ee7cd9f76080c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e584b7a74bfa7836b12b013af6e4e8c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82d63845a51faf022f39fc3a3840ce3f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d907383dbc562e2c882af642dd2eeb21
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c2c86ed01e933fddec7d3760c4df8bb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_45503ed4108deaf230bb0924fd81a5db
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9576ffdc4a8bebfcb85e4102f3032477
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74e1049beaa386dfc8ee787eb820ad1e
date 2020-11-24^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC7686903
https://pubmed.ncbi.nlm.nih.gov/33216886
https://doi.org/10.1182/bloodadvances.2020003345
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/46065
https://portal.issn.org/resource/ISSN/2473-9537
language English
source https://pubmed.ncbi.nlm.nih.gov/
title SF3B1-mutant CMML defines a predominantly dysplastic CMML subtype with a superior acute leukemia-free survival
discusses http://id.nlm.nih.gov/mesh/M0290886
http://id.nlm.nih.gov/mesh/M0016705
http://id.nlm.nih.gov/mesh/M000616694
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D015477
http://id.nlm.nih.gov/mesh/D015470Q000235
hasSubjectTerm http://id.nlm.nih.gov/mesh/D010750
http://id.nlm.nih.gov/mesh/D011379
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000072260
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_20c9040091ee5687de83fe506600d898
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8306

Showing number of triples: 1 to 45 of 45.